Email Updates

You are here


Media Coverage

  • The Department of Health and Human Services stripped from a government website HIV/AIDS educational material that featured condoms, calling the images “unapproved,” according to official correspondence obtained by Kaiser Health News.

    February 28, 2020
  • The introduction of New Zealand's world-first needle exchange programme 30 years ago has helped this country avoid the high rates of HIV found overseas, a study has concluded.

    February 27, 2020
  • The White House sought to show it was shoring up its efforts to corral the spread of coronavirus on Thursday, naming an internationally recognized HIV/AIDS expert as its new coronavirus response coordinator.

    February 27, 2020
  • Some of my patients call them "Skittles." They're small ovaloid morsels that evoke a particular sweetness and pleasure. And they have been a boon in the sex-positive movement in the queer community that has arisen to rival the privilege of relatively worry-free heterosexual sex. Skittles, of course, refers to Truvada (tenofovir disoproxil & emtricitabine), the first FDA-approved medication and currently the only CDC-recommended medication for use in HIV prevention, or pre-exposure prophylaxis (PrEP).

    February 27, 2020
    Philadelphia Gay News
  • On Monday February 3rd it was announced that HVTN 702, a large-scale HIV vaccine efficacy trial taking place in South Africa, had found no evidence of protection against HIV acquisition. The information emerged from a pre-planned review of interim results conducted by the trial’s Data Safety Monitoring Board (DSMB), which revealed roughly equal numbers of HIV infections among vaccine and placebo (dummy vaccine) recipients. There were no indications that the vaccine regimen had caused harm.

    February 26, 2020
    TAG HIV Basic Science, Vaccines, and Cure Project Blog
  • Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting to Zero” — meaning zero new HIV infections — is a slogan used by the World Health Organization and others in fighting the epidemic.

    February 26, 2020
    STAT News
  • On 22 January, Dave O’Connor and Tom Friedrich invited several dozen colleagues around the United States to join a new workspace on the instant messaging platform Slack. The scientists, both at the Wisconsin National Primate Research Center, had seen news about a new disease emerging in China and realized researchers would need a primate model if they were going to answer some important questions about its biology.

    February 26, 2020
  • HIV health care professionals and advocates have been struggling with how to reach the populations that could most benefit from pre-exposure prophylaxis (PrEP) and, when and if these patients access it, help them take their medication daily. A variety of new mobile-friendly online portals and apps are taking on two of the biggest barriers to getting people on PrEP: the lack of doctors who are willing to prescribe it, and the perceived—and often real—difficulties in obtaining it.

    February 26, 2020
    The Body
  • “We have an answer – the regimen simply didn’t work. It feels really grim, though, today.” This was the immediate and heartfelt reaction of one of the principal investigators of the first large-scale HIV efficacy vaccine trial to be launched for nine years – only one of three such 'phase III' trials in the last decade – when I emailed her on 3 February. That was the day it was announced that the HVTN 702 (Uhambo) trial would close, as the experimental vaccine had no efficacy.

    February 24, 2020
  • “May you of a better future, love without a care,” wrote the artist and film-maker Derek Jarman in his final year. It’s a line that returned to me last month as I rode the Eurostar back to London with my colleagues, Marc and Phil. After meetings with sexual health activists from across Belgium, Marc took out the pill-holder he keeps in his pocket when he travels, and swallowed the medication he takes every day. Doing so reminded Phil and I that we should do the same, each of us gulping down a generic formulation of a tablet called Truvada.

    February 22, 2020
    The Guardian
  • New strategies and approaches are needed to address the sexual health needs of middle-aged heterosexuals starting new relationships, research published in Sexually Transmitted Infections suggests. The UK study involved men and women aged between 40 and 59 years with, or considering, new sexual partners after the break-up of a long-term relationship.

    February 21, 2020

Published Research